Lates News

date
20/05/2025
HC Wainwright & Co. is maintaining its rating on Armata Pharmaceuticals (ARMP.US) at buy, adjusted from a buy rating with a target price of $7.00 to a target price of $9.00.
Latest
See all latestmore